Key facts
- Hansel Medical’s last known valuation is $3.0M (May 2025).
- It has raised $720K; the latest was Early Stage VC ($600K) in May 2025.
- Notable investors include Techstars, Wild Tree Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Hansel Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Hansel Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hansel Medical
Developer of asset tracking and management systems designed to improve operational efficiency in healthcare settings. The company's system provides real-time asset tracking through beacons, web and mobile applications, maintenance alerts, reporting tools, and analytics for healthcare facilities, enabling healthcare providers, device manufacturers, and distributors to reduce search time, minimize errors, enhance data-driven decision-making, and improve inventory management while maximizing asset use.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2023
- Employees
- 2
- Website
- hanselmedical.com/
- Ownership
- Privately Held (backing)
Hansel Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hansel Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hansel Medical in its N-PORT filings yet. We sweep new filings monthly.